Fierce Pharma Highlights Pharma’s Shift Toward Direct-to-Patient Models

Fierce Pharma highlights pharma’s shift toward direct-to-patient models A recent Fierce Pharma article examines how pharmaceutical companies are increasingly experimenting with, and scaling, direct-to-patient (DTP) models as part of a broader evolution in commercial strategy. The piece notes that major manufacturers, including Amgen, Bristol Myers Squibb, AstraZeneca, Genentech, Novartis, Boehringer Ingelheim, Eli Lilly, Pfizer, and […] The post Fierce Pharma Highlights Pharma’s Shift Toward Direct-to-Patient Models appeared first on ixlayer .